13th International Congress
13th International Congress

News Release

Monday, June 8, 2009

Media Contact:
Elizabeth Laur, elaur@movementdisorders.org
+1 414-276-2145 (MDS Secretariat)
MDS 13th International Congress Press Room (June 7-11):
Le Palais des Congres de Paris,
Room 212/213, Level 2, Hall Maillot, TEL: +33 (0)1 40 68 63 74

Telemedicine Shown to be Reliable for Patients with Parkinson's Disease

PARIS - A recent study indicates that the use of telemedicine in evaluating patients with Parkinson's disease is reliable and valid, according to research presented today at The Movement Disorder Society's 13th International Congress of Parkinson's Disease and Movement Disorders.

This study, led by Kevin Biglan, MD, MPH, of the University of Rochester, investigates the use of the motor Unified Parkinson's Disease Rating Scale (UPDRS) via a web-based telemedicine program as an assessment of motor function, due to the patient distance from research centers, travel difficulties or clinical condition.

Overall, the study concludes that use of the motor UPDRS is reliable when used via telemedicine in comparison to the standard in-person treatment and assessment of patients with Parkinson's disease.

Christopher Goetz, MD, of Rush University Medical Center in Chicago, states that "Patients with Parkinson's disease have difficulty traveling for expert care, so there is implicit advantage to techniques that allow at-home evaluations. Given that the days of doctors making house calls are largely over, TeleMedical techniques offer the infrastructure for physician experts at a central location to receive clinical information on patients who cannot travel. This information could be used for patient care decisions or medication adjustments that depend on the medical examination findings. Likewise, for research purposes, this technique could be advantageous and obviate the need for required visits to a medical center during a clinical trial."

Meeting attendees are gathered to learn the latest research findings and state-of-the-art treatment options for Movement Disorders, including Parkinson's disease. More than 3,900 physicians and medical professionals from 90 countries will be able to view over 1,700 scientific abstracts submitted by clinicians from around the world.

The Movement Disorder Society, an international society of over 3,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research.

For more information about The Movement Disorder Society, visit www.movementdisorders.org